Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D....
Date2019-11-20
Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D., present our prominent research in non-viral CAR-T therapy in “The Advanced Immuno-Oncology Forum” in Taipei on November 20, 2019.
